AN OVERVIEW OF INCRETIN-BASED THERAPIES: PHARMACOLOGY AND FUTURE PERSPECTIVES

INCRETIN-BASED THERAPY AND CANCER: ARE THEY ENEMIES OR ALLIES?

A Study on the Effect of Glucagon Like Peptide 1 Agonist on Glycemic State, Renal Functions and Some Hemodynamic Parameters in Diabetic Male Albino Rats

Exploring the role of Glucagon-Like Peptide-1 in heart failure with preserved ejection fraction among patients with type 2 Diabetes Mellitus

POTENTIAL ROLE OF GLP-1 RECEPTOR AGONIST IN A RAT MODEL OF CARDIO-RENAL SYNDROME TYPE-3: EFFECTS ON OXIDATIVE, INFLAMMATORY AND INOS EXPRESSION AXIS

Mechanism of the Neuroprotective Effect of GLP-1 in a Rat Model of Parkinson’s with Pre-existing Diabetes

Beneficial effects of sitagliptin ,metformin and their combination on myocardial ischemic and vascular changes in type-two diabetic rats

Saxagliptin beyond glycemic control: a comprehensive review

Role of β-adrenergic receptors in insulin resistance: Induction or protection?

The Role of incretin-based therapies in maintaining glucose homeostasis and management of diabetes mellitus